Amicus Therapeutics is a Cranberry, New Jersey based American biopharmaceutical company. The company focuses on creating treatments for rare, orphan diseases like lysosmal storage disorders. Using a Chaperone-Advanced Replacement Therapy platform, Amicus Therapeutics develops effective enzyme replacement therapies. The company is known for having the pharmaceutical industry’s broadest portfolio went it comes to small molecule pharmacological chaperones. Although Amicus has no marketed products, the pharmacological chaperone treatment migalastat, used to treat Fabry disease, is at an advanced state of development.
Amicus Therapeutics has collaborated with companies like JCR Pharmaceutical, GlaxoSmithKline and Shire to do groundbreaking research and development on effective medical treatments. The company has been trading on NASDAQ under the symbol FOLD since 2007. Prior to that it received funding from New Enterprise Associates, Radius Ventures, Canaan Partners as well as other venture capital firms. Amicus Therapeutics expanded into a second research site in San Diego in 2008. The company doesn’t have its own manufacturing capability. Instead, it relies on contract manufacturing.
The Michael J. Fox Foundation gave Amicus Therapeutics a $500,000 grant in 2010 to help support the company’s collaborative studies with UCLA’s David Geffen School of Medicine. The Alzheimer’s Drug Discovery Foundation gave Amicus Therapeutics a $210,300 grant that same year in support of the pre-clinical work the company was doing at the Alzheimer’s Disease Research Center as part of a collaboration at Mount Sinai with the Icahn School of Medicine.
Amicus Therapeutics acquired Callidus Biopharma, one of it’s competitors in 2013. This gave Amicus the intellectual property and proprietary materials necessary for the creation of the enzyme replacement therapy treatment used for Pompe disease. The company continued to grow in 2015 when it paid cash and stock of $947 million to acquire Scioderm (Google Finance).
One key member of the company’s corporate governance team is John F. Crowley. He has been CEO since 2005 and became chairman of the board in 2010. The COO is Bradley L Campbell and William D. Baird III is CFO. Former board chairman Donald Hayden, Jr. is now the company’s Lead Independent Director. The Chief Scientific Officer of Amicus Therapeutics is David Lockhart.
Looking to work for Amicus Therapeutics? Indeed
Securus Technologies isn’t your ordinary form of communications, as it’s one that’s enabling visitors of inmates and inmates themselves to communicate with one another via methods of videoconferencing in which the visitors are not required to physically travel to the inmate’s place of confinement. If you’re needing to speak with a representative of Securus Technologies to learn more about the program, please refer to the website, as contact details are available on there. Also, if you’re wanting to find a list of which correctional facilities have already proceeded with having the program installed, then that is something that you may be able to find on the website as well.
Securus Technologies consists of a safe, secure, and fast platform in which its immediate users can speak to one another without worrying about any unwanted/third party eavesdropping. This is often a concern of anyone who engages in any other forms of communications in which fact to face contact is not conducted. The only other parties that will have access to the videoconferencing sessions are law enforcement agencies and the courts if matters of illegal activities are discussed within them. This is exactly why the program of Securus Technologies has become a deterrent of crimes in a great way, as inmates are not only avoiding speaking about matters of illegal activities that may be taking place within their areas of confinement, but from engaging in them altogether, as they’re aware that others who conduct visitation sessions through the Securus Technologies program can end up talking about anything they engage in with their respective visitors. If you’re wanting to receive assistance with utilizing the program, then it’s recommended for you to go to the website to see what the options of contacting a help desk assistant may be. You will find the program is certainly one that’s worth utilizing.
Securus Technologies offers an opportunity in which people are connect with others through the utilization of video chatting through an interface of a program that has been beautifully designed and engineered to give inmates an opportunity of connecting with those who they may consider to be friends, significant others, or relatives in a “face to face” scenario without actually being next to one another. This is made possible by a technology that brings video conferencing into a correctional facility’s environment.
Visitors are no longer obligated to wait in lines or schedule appointments during times that are inconvenient for them. They can simply open the Securus Technologies program to chat with their friend, significant other, or relative through the program by setting their own schedules. It is however important to see whether or not the correctional facility your friend, relative, or significant other may be incarcerated at is currently offering the utilization of this program.
Securus Technologies is a BBB accredited company that has been given approval to continue its operations. They’ve been proven to be a quality company that has made a program that’s greatly benefited many different types of people. It is a program that’s had effects of helping communities by solving crimes as the conversations that take place within the video conferencing sessions of Securus Technologies can be used as evidence by police officers in which they’ll be able to begin investigative efforts to potentially stop the crimes that may have been spoken about. It is a program that provides an all around spectrum of benefits for many different people. If you’re wanting to become more acquainted with the program and its interface, please feel free to contact one of the customer service technicians to provide you with the guidance that you may require to begin utilizing this program. Be sure to check on the prices on the website as well. You will see that rates are quite low in comparison to other forms of communicative technologies.